The Different Pathways for Treatment of Pulmonary Hypertension

There are three pathways that we can approach with FDA approved drugs for pulmonary hypertension. No cedentaphil can be given IV so patients who are too real or can't take POs or vomiting. It's also important to recognize that many institutions don't have access to all those drugs or delivery systems to give them. If there's an issue where they're not getting their drug you just put in a regular IV and hook it up.